Saklaspur Bio Tech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-12-2024
- Paid Up Capital ₹ 1.71 Cr
as on 24-12-2024
- Company Age 26 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.00 M
as on 24-12-2024
About Saklaspur Bio Tech
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.71 Cr.
The company has closed loans amounting to ₹2.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Suresh Venkatakrishnaiah and Moodalamakki Sathyanarayana serve as directors at the Company.
- CIN/LLPIN
U24219KA1998PTC023924
- Company No.
023924
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Saklaspur Bio Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Venkatakrishnaiah  | Director | 03-Jul-1998 | Current |
| Moodalamakki Sathyanarayana | Director | 03-Jul-1998 | Current |
Financial Performance of Saklaspur Bio Tech.
Saklaspur Bio Tech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Saklaspur Bio Tech?
In 2017, Saklaspur Bio Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saklaspur Organics Private LimitedActive 44 years 11 monthsSuresh Venkatakrishnaiah is a mutual person
- Greans India Chemicals Private LimitedActive 22 years 5 months
Suresh Venkatakrishnaiah is a mutual person
- Saklaspur Agro-Chem Private LimitedActive 40 years 9 months
Suresh Venkatakrishnaiah is a mutual person
- Contropest (India)Chemicals Private LimitedActive 29 years 10 months
Suresh Venkatakrishnaiah and Moodalamakki Sathyanarayana are mutual person
- Saklaspur Engineering Private LimitedActive 42 years 6 months
Suresh Venkatakrishnaiah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Ltd Creation Date: 19 Mar 2000 | ₹2.00 M | Satisfied |
How Many Employees Work at Saklaspur Bio Tech?
Unlock and access historical data on people associated with Saklaspur Bio Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saklaspur Bio Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saklaspur Bio Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
